BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ · Manufacturing · Pharmaceutical preparations
$3.95−$0.0400 (−1.00%) on the dayAs of the close; data may be delayed.
BBOT price, last 12 months
Key stats
- Previous close
- $3.99
- Open
- $4.00
- Day range
- $3.89 – $4.00
- 52-week range
- $3.89 – $14.87
- Volume
- 523.6K
- Avg volume (20 days)
- 708.7K
- Market cap
- $316.7M
Performance
1W−17.2%
1M−57.3%
3M−46.6%
6M−57.2%
YTD−68.5%
1Y−65.3%
vs S&P 500, 1Y−82.1 pts
Technicals and fundamentals
About BridgeBio Oncology Therapeutics, Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $316.7M